Blog

Baris Turkbey: Low- and High-Volume Disease in Metastatic Hormone-Sensitive Prostate Cancer

drpetroniomelo.com.br

Jan 8, 2025, 15:08

Baris Turkbey: Low- and High-Volume Disease in Metastatic Hormone-Sensitive Prostate Cancer

Baris Turkbey, Head of the Magnetic Resonance Imaging section in MIB, shared post on X:

“Low- and High-Volume Disease in Metastatic Hormone-Sensitive Prostate Cancer: From CHAARTED to PSMA PET-An International Multicenter Retrospective Study

– Compared with conventional imaging, addition of PSMA PET leads to M0 downstaging in every third and LVD to HVD upstaging in every fifth metastatic hormone-sensitive prostate cancer patient.

– Future HVD and LVD definitions based on PSMA PET/CT should be adjusted based on patient outcome.”

Low- and High-Volume Disease in Metastatic Hormone-Sensitive Prostate Cancer: From CHAARTED to PSMA PET—An International Multicenter Retrospective Study

Authors: Lena M. Unterrainer et al.

Amar U. Kishan Baris Turkbey cancer Francesco Barbato Honest Ndlovu Johannes Czernin and Jeremie Calais Ken Herrmann Lena M. Unterrainer Matthew B. Rettig Matthias R. Benz Mike Sathekge OncoDaily Oncology Thomas A. Hope Tristan Grogan Wesley Armstrong Wolfgang P. Fendler

Senator John Fetterman Responds to Oncodaily on Pediatric Oncology Funding

Does Processed Meat Cause Cancer? Myths and Facts

Global Health Dialogues with Princess Dina Mired | Episode 1: Dr. Firas Al-Hawari

NEW PAPER ALERT: ESOPEC trial on Perioperative Chemotherapy or Preoperative Chemoradiotherapy in Esophageal Cancer

Oncologist Near Me - Matti Aapro: Pioneering Excellence in Cancer Care and Geriatric Oncology